• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病对药物洗脱支架置入术后早期动脉愈合的影响。

Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation.

机构信息

Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabaso, Amagasaki, 660-8511, Hyogo, Japan.

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

出版信息

Cardiovasc Diabetol. 2020 Dec 2;19(1):203. doi: 10.1186/s12933-020-01173-7.

DOI:10.1186/s12933-020-01173-7
PMID:33267863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709345/
Abstract

BACKGROUND

Early arterial healing after drug-eluting stent (DES) implantation may enable short dual-antiplatelet therapy (DAPT) strategy. The impact of diabetes mellitus (DM) on this healing has not been elucidated. We used coronary angioscopy (CAS) to compare intravascular status of DM and non-DM patients in the early phase after DES implantation.

METHODS

This study was a multicenter retrospective observational study. We analyzed CAS findings of 337 lesions from 270 patients evaluated 3-5 months after DES implantation. We divided the lesion into two groups: DM (n = 149) and non-DM (n = 188). We assessed neointimal coverage (NIC) grades (dominant, maximum and minimum), thrombus adhesion and maximum yellow color grade. NIC was graded as follows: grade 0, stent struts were not covered; grade 1, stent struts were covered by thin layer; grade 2, stent struts were buried under neointima. Yellow color was graded as grade 0, white; grade 1, light yellow; grade 2, yellow; grade 3, intensive yellow.

RESULTS

Minimum NIC grade was significantly lower in DM than in non-DM groups (p = 0.002), whereas dominant and maximum NIC grades were similar between them (p = 0.59 and p = 0.94, respectively), as were thrombus adhesion (44.3% vs. 38.8%, p = 0.32) and maximum yellow color grade (p = 0.78). A multivariate analysis demonstrated that DM was an independent predictor of minimum NIC of grade 0 (odds ratio: 2.14, 95% confidence interval: 1.19-3.86, p = 0.011).

CONCLUSIONS

DM patients showed more uncovered struts than non-DM patients 3-5 months after DES implantation, suggesting that the recent ultra-short DAPT strategy might not be easily applied to DM patients.

摘要

背景

药物洗脱支架(DES)植入后早期动脉愈合可实现短程双联抗血小板治疗(DAPT)策略。糖尿病(DM)对这种愈合的影响尚未阐明。我们使用冠状动脉血管镜(CAS)比较了 DES 植入后早期 DM 和非 DM 患者的血管内状态。

方法

这是一项多中心回顾性观察研究。我们分析了 270 例患者 3-5 个月后接受 DES 植入后 337 个病变的 CAS 结果。我们将病变分为两组:DM(n=149)和非 DM(n=188)。我们评估了新生内膜覆盖(NIC)等级(主导、最大和最小)、血栓黏附以及最大黄色等级。NIC 分级如下:0 级,支架小梁未被覆盖;1 级,支架小梁被薄的新生内膜覆盖;2 级,支架小梁被新生内膜下埋。黄色分级为:0 级,白色;1 级,浅黄;2 级,黄色;3 级,深黄。

结果

DM 组的最小 NIC 分级明显低于非 DM 组(p=0.002),而主导和最大 NIC 分级相似(p=0.59 和 p=0.94),血栓黏附(44.3% vs. 38.8%,p=0.32)和最大黄色分级(p=0.78)也相似。多变量分析表明,DM 是 NIC 分级为 0 级的独立预测因子(比值比:2.14,95%置信区间:1.19-3.86,p=0.011)。

结论

DES 植入后 3-5 个月,DM 患者的支架小梁未被覆盖的比例高于非 DM 患者,这表明最近的超短 DAPT 策略可能不易应用于 DM 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9943/7709345/edeb24c576fd/12933_2020_1173_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9943/7709345/edeb24c576fd/12933_2020_1173_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9943/7709345/edeb24c576fd/12933_2020_1173_Fig1_HTML.jpg

相似文献

1
Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation.糖尿病对药物洗脱支架置入术后早期动脉愈合的影响。
Cardiovasc Diabetol. 2020 Dec 2;19(1):203. doi: 10.1186/s12933-020-01173-7.
2
Comparison of neointimal coverage between durable-polymer everolimus-eluting stents and bioresorbable-polymer everolimus-eluting stents 1 year after implantation using high-resolution coronary angioscopy.应用高分辨率冠状动脉血管内成像术比较 1 年后药物洗脱支架的新生内膜覆盖率:可降解聚合物依维莫司洗脱支架与耐用聚合物依维莫司洗脱支架。
Catheter Cardiovasc Interv. 2019 Aug 1;94(2):204-209. doi: 10.1002/ccd.28095. Epub 2019 Feb 9.
3
Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.西罗莫司药物洗脱支架上形成的动脉粥样硬化和血栓形成性新生内膜:一项血管内镜研究。
JACC Cardiovasc Imaging. 2009 May;2(5):616-24. doi: 10.1016/j.jcmg.2008.12.026.
4
Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).药物涂层外周支架植入后抑制下肢动脉病变血管壁愈合的观察(SHIMEJI 研究):血管内超声观察紫杉醇洗脱镍钛诺自膨式支架在股浅动脉病变中的血管反应
Int J Cardiovasc Imaging. 2019 Oct;35(10):1777-1784. doi: 10.1007/s10554-019-01638-1. Epub 2019 Jun 14.
5
Angioscopy study from a large patient population comparing sirolimus-eluting stent with biodegradable versus durable polymer.从大型患者人群比较研究来看,与生物可降解聚合物相比,西罗莫司洗脱支架具有优势。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):420-8. doi: 10.1002/ccd.23306. Epub 2012 Jan 10.
6
Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.糖尿病对药物洗脱支架时代血管反应的影响:荟萃容积血管内超声分析。
Circ Cardiovasc Interv. 2012 Dec;5(6):763-71. doi: 10.1161/CIRCINTERVENTIONS.111.962878. Epub 2012 Nov 13.
7
Angioscopic Assessments at 3 Months After Fluoropolymer-Based Paclitaxel-Eluting Stent Implantation for Femoropopliteal Endovascular Intervention.氟聚合物载紫杉醇洗脱支架置入治疗股腘动脉腔内介入 3 个月后的血管内镜评估。
Circ J. 2020 Oct 23;84(11):1999-2005. doi: 10.1253/circj.CJ-20-0551. Epub 2020 Sep 26.
8
Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents.经依维莫司洗脱支架与西罗莫司洗脱支架置入 9 个月后的冠状动脉血管内超声检查结果比较。
J Cardiol. 2013 Jan;61(1):22-30. doi: 10.1016/j.jjcc.2012.08.011. Epub 2012 Oct 15.
9
Arterial repair 4 months after zotarolimus-eluting stent implantation observed on angioscopy.经血管镜观察到,在接受佐他莫司洗脱支架置入 4 个月后出现的动脉修复。
Circ J. 2013;77(5):1186-92. doi: 10.1253/circj.cj-12-1369. Epub 2013 Feb 15.
10
Satisfactory arterial repair 1 year after ultrathin strut biodegradable polymer sirolimus-eluting stent implantation: an angioscopic observation.超薄支撑可生物降解聚合物西罗莫司洗脱支架植入术后1年动脉修复情况良好:血管内镜观察
Cardiovasc Interv Ther. 2019 Jan;34(1):34-39. doi: 10.1007/s12928-018-0510-4. Epub 2018 Jan 15.

引用本文的文献

1
Long-Term Outcomes Following Percutaneous Coronary Intervention With Rotational Atherectomy for Severely Calcified Lesions.严重钙化病变经皮冠状动脉介入旋磨术的长期预后
Circ Rep. 2025 Jun 17;7(7):528-534. doi: 10.1253/circrep.CR-25-0061. eCollection 2025 Jul 10.
2
Intravascular Imaging and Angiography Guidance in Complex Percutaneous Coronary Intervention Among Patients With Diabetes: A Secondary Analysis of a Randomized Clinical Trial.血管内影像学和血管造影指导在糖尿病患者复杂经皮冠状动脉介入治疗中的应用:一项随机临床试验的二次分析。
JAMA Netw Open. 2024 Jun 3;7(6):e2417613. doi: 10.1001/jamanetworkopen.2024.17613.
3

本文引用的文献

1
Healthy Strut Coverage After Coronary Stent Implantation: An Ex Vivo Human Autopsy Study.冠状动脉支架植入术后的健康步态覆盖:一项人体解剖外研究。
Circ Cardiovasc Interv. 2020 May;13(5):e008869. doi: 10.1161/CIRCINTERVENTIONS.119.008869. Epub 2020 Apr 27.
2
Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.与无糖尿病患者相比,经胰岛素治疗和未经胰岛素治疗的糖尿病对当代经皮冠状动脉介入治疗(PCI)后 1 年结局的影响。
Catheter Cardiovasc Interv. 2020 Aug;96(2):298-308. doi: 10.1002/ccd.28841. Epub 2020 Mar 12.
3
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
Long-term clinical outcomes of Chinese diabetic patients after coronary revascularization with drug-eluting stents: a retrospective comparative cohort study.
中国糖尿病患者药物洗脱支架冠状动脉血运重建术后的长期临床结局:一项回顾性比较队列研究
Ann Transl Med. 2022 Nov;10(22):1206. doi: 10.21037/atm-22-4517.
4
The Impact of Diabetes on Vascular Disease: Progress from the Perspective of Epidemics and Treatments.糖尿病对血管疾病的影响:从流行病学和治疗角度看进展
J Diabetes Res. 2022 Apr 8;2022:1531289. doi: 10.1155/2022/1531289. eCollection 2022.
5
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.在两项大规模随机临床试验中,新代药物洗脱支架治疗的患者中糖尿病前期和糖尿病对 3 年结局的影响。
Cardiovasc Diabetol. 2021 Oct 30;20(1):217. doi: 10.1186/s12933-021-01405-4.
6
Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective.2型糖尿病与心肌梗死:最新临床证据与展望
Front Cardiovasc Med. 2021 Feb 24;8:644189. doi: 10.3389/fcvm.2021.644189. eCollection 2021.
糖化变异性比糖化血红蛋白在识别行经皮冠状动脉介入治疗的 2 型糖尿病伴高血小板反应患者中的增量作用。
Cardiovasc Diabetol. 2019 Nov 9;18(1):147. doi: 10.1186/s12933-019-0952-8.
4
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.1 个月双联抗血小板治疗后序贯氯吡格雷与 12 个月双联抗血小板治疗对 PCI 患者心脑血管及出血事件的影响:STOPDAPT-2 随机临床试验。
JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145.
5
Early- and middle-phase arterial repair following bioresorbable- and durable-polymer drug-eluting stent implantation: An angioscopic study.生物可吸收聚合物和耐用聚合物药物洗脱支架置入后早期和中期动脉修复:血管镜研究。
Int J Cardiol. 2019 Jun 15;285:27-31. doi: 10.1016/j.ijcard.2019.02.059. Epub 2019 Feb 28.
6
Predictors of strut coverage of drug eluting stent implantation in diabetic patients.预测糖尿病患者药物洗脱支架置入术后支架覆盖率的因素。
Int J Cardiol. 2019 Feb 1;276:61-65. doi: 10.1016/j.ijcard.2018.11.025. Epub 2018 Nov 9.
7
Impact of the one-year angioscopic findings on long-term clinical events in 504 patients treated with first-generation or second-generation drug-eluting stents: the DESNOTE-X study.504 例接受第一代或第二代药物洗脱支架治疗的患者中,一年血管镜检查结果对长期临床事件的影响:DESNOTE-X 研究。
EuroIntervention. 2019 Sep 20;15(7):631-639. doi: 10.4244/EIJ-D-18-00660.
8
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.药物洗脱支架置入术后 ST 段抬高型心肌梗死(DAPT-STEMI)患者 6 个月与 12 个月双联抗血小板治疗:随机、多中心、非劣效性试验。
BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.
9
Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting.糖代谢受损与接受血管成形术和支架置入术的患者的凝血酶生成潜力增加有关。
Cardiovasc Diabetol. 2018 Sep 29;17(1):131. doi: 10.1186/s12933-018-0774-0.
10
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.急性冠状动脉综合征患者经皮冠状动脉介入治疗后 6 个月与 12 个月或更长时间双联抗血小板治疗(SMART-DATE):一项随机、开放标签、非劣效性试验。
Lancet. 2018 Mar 31;391(10127):1274-1284. doi: 10.1016/S0140-6736(18)30493-8. Epub 2018 Mar 12.